Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 12/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12040642 | 1.00 | SIGMAR1 (0.50) | SIGMAR1L3MBTL1MAOAMAPTRXFP1 | |
| SCHEMBL31651216 | 0.98 | L3MBTL1 (0.48) | SIGMAR1L3MBTL1MAOAMAOB | |
| SCHEMBL5583576 | 0.92 | L3MBTL1 (0.45) | SIGMAR1L3MBTL1MAOAMAOB | |
| SCHEMBL27985647 | 0.83 | SIGMAR1 (0.52) | SIGMAR1L3MBTL1MAOAMAPTRXFP1 | |
| SCHEMBL6868253 | 0.83 | ALDH1A1 (0.44) | MAOAMAOB | |
| Hydrochloric Acid SCHEMBL392159 | 0.82 | SIGMAR1 (0.52) | SIGMAR1L3MBTL1MAOAMAPTRXFP1 | |
| Hydrochloric Acid SCHEMBL9442792 | 0.82 | SIGMAR1 (0.52) | SIGMAR1L3MBTL1MAOAMAPTRXFP1 | |
| SCHEMBL779931 | 0.81 | MAOA (0.52) | SIGMAR1L3MBTL1MAOAMAPTRXFP1 | |
| SCHEMBL12040649 | 0.81 | SIGMAR1 (0.47) | SIGMAR1L3MBTL1MAOAMAPTRXFP1 | |
| SCHEMBL14423594 | 0.80 | SIGMAR1 (0.48) | SIGMAR1L3MBTL1MAOAMAPTRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170196854-A1 | USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS | INTERVET INC. (US) | 2017-07-13 | — | — | US | disclosed |
| US-9096524-B2 | Anthelmintic agents and their use | INTERVET INTERNATIONAL B.V. (NL) | 2015-08-04 | — | — | US | disclosed |
| US-20110319393-A1 | ANTHELMINTIC AGENTS AND THEIR USE | INTERVET INTERNATIONAL B.V. (NL) | 2011-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319393-A1 | ANTHELMINTIC AGENTS AND THEIR USE | ACHE, ABCB11, MPO | SIGMAR1 4049/4885L3MBTL1 4172/4885MAOA 1937/4885 |
| US-20170196854-A1 | USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS | MPO, DHODH, DHX35 | SIGMAR1 4211/4885L3MBTL1 1785/4885MAOA 2133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.